Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Endocrinology|June 1, 1987
Effect of hypothyroidism and thyroid hormone replacement in vivo on pituitary cytoplasmic concentrations of thyrotropin-beta and alpha-subunit messenger ribonucleic acidsJ A Franklyn, D F Wood, N J Balfour, et al.
Molecular and Cellular Endocrinology|October 19, 2005
Uncoupling proteins: targets of endocrine disruptors?T Pawade, P W L Ho, K H-H Kwok, et al.
Clinical Endocrinology|June 1, 1977
Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormoneR Hoffenberg, A Howell, S Epstein, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Theoretical considerations for improving tumour targetingG D Thomas, M J Chappell, P W Dykes, et al.
Clinical Endocrinology|July 1, 1989
Is oleic acid the thyroxine binding inhibitor in the serum of ill patients?I G Haynes, S J Lockett, M J Farmer, et al.
Cancer Research|June 15, 1989
Effect of dose, molecular size, affinity, and protein binding on tumor uptake of antibody or ligand: a biomathematical modelG D Thomas, M J Chappell, P W Dykes, et al.
International Journal of Andrology|March 21, 2012
Detection of endocrine disruptors - from simple assays to whole genome scanningE Sung, N Turan, P W-L Ho, et al.
Liver|March 22, 2000
Reduced hepatic content of dehydroepiandrosterone sulphotransferase in chronic liver diseasesO T Elekima, C O Mills, A Ahmad, et al.
Lancet (London, England)|August 29, 1981
Serum thyroglobulin in thyroid cancerE G Black, A Cassoni, T M Gimlette, et al.
Physics in Medicine and Biology|May 1, 1986
Preliminary assessment of a multiwire camera for quantitative autoradiography of tritium-labelled substancesS J Lockett, A R Bradwell, J E Bateman, et al.
Pageof 14